{"ticker": {"uuid": "09a765a6-ba21-4f46-b556-bc1faac157b2", "symbol": "CRTX", "name": "CRISM Therapeutics Corporation", "exchange": "LSE", "country": "GB", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Crism completes manufacture of first ChemoSeed chemical batch", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOQXhGU1Y0WHZrWDBvWnltSTRicGdrVC11RVJCUjYwR3NQXzJKYmJId280bXZBcE9ha3RiUy0xaXNmRDFBOXlITTVCVVcyRWp0NUZKdGF1Mmc0QjJLTHhRc1hLQVg4bkllenc0Z0RKQkdaT2c4TS13dXpjbHNNUzd3OWwyRHowLTZrNzdLc0NocFRaRlUxM2NjemlYcmNrNWJTUkxVYjhRdEtIcGdnRDJUdVo2YTdtcDJkeTVyXw?oc=5", "source_name": "Sharecast.com", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CRISM Therapeutics shares jump 12% after FDA grants orphan drug status for brain cancer treatment", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxORHF2azdKcmsxWU9FaEJVUFRqRjZqSWJmUkJCWFBZeThOSmRtc1BlZ2J6cXRMa2xkMkJ1QTZURXhyQ2QxWXhQQkxweUdTaXo3eTBVY3RXVFQ3YWRqOWRLQWt0V3NmOW5CZnFwcjhGbVRuelVwVVBDRFhra3pGLU1sSUY3aFJKak9ZRWc?oc=5", "source_name": "Market source", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Crism Therapeutics gets clearance for UK phase 2 trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxNeFh5Y1pnVlV6blRMNzR5WUNudlk4QW5wOGFLZlF0WXRCdzRNOURmTWNJcEk3U3lpeXYtOFVxT3ZEa0JLME04dEdTZnluNVFWVG02LVVmMTVtMkticjN3cUlYYXhRbmNFM2NvXzdIc3VpM0hYVjM3ZTFhWnRVZ0VUSnVPV1RmMFVjUUlwOUd0SWdWbzRZdzBmeEg3TU1DM2doZUs2RnpPRndkM0xKQkVMM2txNA?oc=5", "source_name": "Sharecast.com", "published_at": "2025-09-01T07:00:00+00:00", "published_display": "01 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CRTX Stock Price and Chart \u2014 LSE:CRTX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTFByZXBBYWZ4Q0NzbkprZkl6MjZOYXV5UU02TGF0YmE3eFNXUWo4MjNFYUJ3THdyT2dlUkFabUNGY0NFbm4zWW5oWGZMS2lHaGZsREdKcS1ZQ0o?oc=5", "source_name": "TradingView", "published_at": "2024-05-31T08:48:16+00:00", "published_display": "31 May 2024 08:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quince Therapeutics (QNCX) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFBBNTY1cjVJSEliZkFkQnNkWE5SNDRGZ0VYcmRXMEhKaWhEd05uZnpfdllNN29iMFFNSlJUZmt0V3pweUdBVXhCaE9ZOW44OWxfeGhOU0dlbzlDZw?oc=5", "source_name": "MarketBeat", "published_at": "2022-08-04T13:01:09+00:00", "published_display": "04 Aug 2022 13:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Crism completes manufacture of first ChemoSeed chemical batch", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOQXhGU1Y0WHZrWDBvWnltSTRicGdrVC11RVJCUjYwR3NQXzJKYmJId280bXZBcE9ha3RiUy0xaXNmRDFBOXlITTVCVVcyRWp0NUZKdGF1Mmc0QjJLTHhRc1hLQVg4bkllenc0Z0RKQkdaT2c4TS13dXpjbHNNUzd3OWwyRHowLTZrNzdLc0NocFRaRlUxM2NjemlYcmNrNWJTUkxVYjhRdEtIcGdnRDJUdVo2YTdtcDJkeTVyXw?oc=5", "source_name": "Sharecast.com", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CRISM Therapeutics shares jump 12% after FDA grants orphan drug status for brain cancer treatment", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxORHF2azdKcmsxWU9FaEJVUFRqRjZqSWJmUkJCWFBZeThOSmRtc1BlZ2J6cXRMa2xkMkJ1QTZURXhyQ2QxWXhQQkxweUdTaXo3eTBVY3RXVFQ3YWRqOWRLQWt0V3NmOW5CZnFwcjhGbVRuelVwVVBDRFhra3pGLU1sSUY3aFJKak9ZRWc?oc=5", "source_name": "Market source", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Crism Therapeutics gets clearance for UK phase 2 trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxNeFh5Y1pnVlV6blRMNzR5WUNudlk4QW5wOGFLZlF0WXRCdzRNOURmTWNJcEk3U3lpeXYtOFVxT3ZEa0JLME04dEdTZnluNVFWVG02LVVmMTVtMkticjN3cUlYYXhRbmNFM2NvXzdIc3VpM0hYVjM3ZTFhWnRVZ0VUSnVPV1RmMFVjUUlwOUd0SWdWbzRZdzBmeEg3TU1DM2doZUs2RnpPRndkM0xKQkVMM2txNA?oc=5", "source_name": "Sharecast.com", "published_at": "2025-09-01T07:00:00+00:00", "published_display": "01 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CRTX Stock Price and Chart \u2014 LSE:CRTX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTFByZXBBYWZ4Q0NzbkprZkl6MjZOYXV5UU02TGF0YmE3eFNXUWo4MjNFYUJ3THdyT2dlUkFabUNGY0NFbm4zWW5oWGZMS2lHaGZsREdKcS1ZQ0o?oc=5", "source_name": "TradingView", "published_at": "2024-05-31T08:48:16+00:00", "published_display": "31 May 2024 08:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quince Therapeutics (QNCX) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFBBNTY1cjVJSEliZkFkQnNkWE5SNDRGZ0VYcmRXMEhKaWhEd05uZnpfdllNN29iMFFNSlJUZmt0V3pweUdBVXhCaE9ZOW44OWxfeGhOU0dlbzlDZw?oc=5", "source_name": "MarketBeat", "published_at": "2022-08-04T13:01:09+00:00", "published_display": "04 Aug 2022 13:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 65, "total_relevant": 5, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 5, "score": 50, "total": 5, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 2.75, "count": 5}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.1, "latest_week": "2026-07-10", "one_week_move": -2.4, "four_week_move": -2.4, "twelve_week_move": -12.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.866358, "market_dynamics_buy_signal": false, "relative_strength": -13.343002, "fair_value_gap": -20.0, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 22.3948, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.4% over one week, -2.4% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 59, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Sharecast.com", "count": 2}, {"label": "Market source", "count": 1}, {"label": "TradingView", "count": 1}, {"label": "MarketBeat", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 5}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 5}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "5", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-2.4% over one week, -2.4% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Crism completes manufacture of first ChemoSeed chemical batch"}], "updated_at": "2026-07-17T09:16:29.919199+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}